AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) share are climbing nearly 9% in pre-market trading Monday, after the drug maker announced that the European Commission (EC) has …
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported financial results for the second quarter ended June 30, 2017, and provided a business update.
New insights emerge in the biotech sector as Cara Therapeutics Inc (NASDAQ:CARA) released mixed results from a phase 2b trial of the company’s pain medication, …
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) stock tumbled nearly 9% in early trading Tuesday, after the drug maker announced that it has secured $14 million in …
AVEO Pharmaceuticals Shares Skyrocket on Positive CHMP Opinion It’s a very rewarding trading day for investors in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) with shares up over …
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) and Biodesix announced the presentation of results from two investigator-sponsored Phase 1 studies of ficlatuzumab at the 2017 American Society …
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) investors are having a rough morning, after the drug maker announced that it has priced an underwritten public offering of …
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported financial results for the third quarter ended September 30, 2016.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced that the first patient has been dosed in the Company’s pivotal TIVO-3 trial, a randomized, controlled, multi-center, open-label study …
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced private placement of 17,642,482 units, consisting of one share of common stock and a warrant to purchase one share …
